相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms
Debra Van Egeren et al.
EXPERIMENTAL HEMATOLOGY (2022)
Life histories of myeloproliferative neoplasms inferred from phylogenies
Nicholas Williams et al.
NATURE (2022)
In utero origin of myelofibrosis presenting in adult monozygotic twins
Nikolaos Sousos et al.
NATURE MEDICINE (2022)
Museum of spatial transcriptomics
Lambda Moses et al.
NATURE METHODS (2022)
Into the multiverse: advances in single-cell multiomic profiling
Silvia Ogbeide et al.
TRENDS IN GENETICS (2022)
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D. Khoury et al.
LEUKEMIA (2022)
Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects
Neil A. Robertson et al.
NATURE MEDICINE (2022)
Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing
Ella R. Thompson et al.
HAEMATOLOGICA (2021)
Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling
Caleb A. Lareau et al.
NATURE BIOTECHNOLOGY (2021)
Spatiotemporal analysis of human intestinal development at single-cell resolution
David Fawkner-Corbett et al.
CELL (2021)
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
Nils B. Leimkuhler et al.
CELL STEM CELL (2021)
JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality
Tata Nageswara Rao et al.
BLOOD (2021)
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms
Jingyuan Tong et al.
CELL STEM CELL (2021)
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Debra Van Egeren et al.
CELL STEM CELL (2021)
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia
Feng Wang et al.
NATURE COMMUNICATIONS (2021)
Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
The multiple myeloma microenvironment is defined by an inflammatory stromal cell landscape
Madelon M. E. de Jong et al.
NATURE IMMUNOLOGY (2021)
The triumphs and limitations of computational methods for scRNA-seq
Peter V. Kharchenko
NATURE METHODS (2021)
Prognostic impact of RAS-pathway mutations in patients with myelofibrosis
Fabio P. S. Santos et al.
LEUKEMIA (2020)
Single-cell analysis based dissection of clonality in myelofibrosis
Elena Mylonas et al.
NATURE COMMUNICATIONS (2020)
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
Shanshan Pei et al.
CANCER DISCOVERY (2020)
Leukemia secondary to myeloproliferative neoplasms
Andrew J. Dunbar et al.
BLOOD (2020)
Bone marrow niche dysregulation in myeloproliferative neoplasms
Natalia Curto-Garcia et al.
HAEMATOLOGICA (2020)
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets
Bethan Psaila et al.
MOLECULAR CELL (2020)
Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer
Yonatan Katzenelenbogen et al.
CELL (2020)
Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients
Korsuk Sirinukunwattana et al.
BLOOD ADVANCES (2020)
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
Giacomo Coltro et al.
BLOOD ADVANCES (2020)
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard et al.
NATURE MEDICINE (2020)
Single-cell multiomics: technologies and data analysis methods
Jeongwoo Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
High throughput error corrected Nanopore single cell transcriptome sequencing
Kevin Lebrigand et al.
NATURE COMMUNICATIONS (2020)
Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells
Erik L. Bao et al.
NATURE (2020)
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz et al.
BLOOD ADVANCES (2020)
The stem/progenitor landscape is reshaped in a mouse model of essential thrombocythemia and causes excess megakaryocyte production
Daniel Prins et al.
SCIENCE ADVANCES (2020)
TARGET-Seq: A Protocol for High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing
Alba Rodriguez-Meira et al.
STAR PROTOCOLS (2020)
Single-cell mutation analysis of clonal evolution in myeloid malignancies
Linde A. Miles et al.
NATURE (2020)
Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing
Alba Rodriguez-Meira et al.
MOLECULAR CELL (2019)
A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia
Ninib Baryawno et al.
CELL (2019)
The bone marrow microenvironment at single-cell resolution
Anastasia N. Tikhonova et al.
NATURE (2019)
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia
Christine M. McMahon et al.
CANCER DISCOVERY (2019)
Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
Sabrina Cordua et al.
BLOOD (2019)
Somatic mutations and cell identity linked by Genotyping of Transcriptomes
Anna S. Nam et al.
NATURE (2019)
Haematopoiesis in the era of advanced single-cell technologies
Sten Eirik W. Jacobsen et al.
NATURE CELL BIOLOGY (2019)
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: association with age, hydroxyurea administration, disease type and JAK2 mutational status
B. Kubesova et al.
LEUKEMIA (2018)
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Robert L. Bowman et al.
CELL STEM CELL (2018)
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Tiziano Barbuil et al.
LEUKEMIA (2018)
Clonal analysis of lineage fate in native haematopoiesis
Alejo E. Rodriguez-Fraticelli et al.
NATURE (2018)
Deep Convolutional Neural Networks Enable Discrimination of Heterogeneous Digital Pathology Images
Pegah Khosravi et al.
EBIOMEDICINE (2018)
Perivascular Niche Cells Sense Thrombocytopenia and Activate Platelet-Biased Hscs in an IL-1 Dependent Manner
Tiago C. Luis et al.
EXPERIMENTAL HEMATOLOGY (2018)
Prediction of acute myeloid leukaemia risk in healthy individuals
Sagi Abelson et al.
NATURE (2018)
Hierarchically related lineage-restricted fates of multipotent haematopoietic stem cells
Joana Carrelha et al.
NATURE (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53
Bridget K. Marcellino et al.
BLOOD ADVANCES (2018)
Targeting the CALR interactome in myeloproliferative neoplasms
Elodie Pronier et al.
JCI INSIGHT (2018)
Simultaneous epitope and transcriptome measurement in single cells
Marlon Stoeckius et al.
NATURE METHODS (2017)
Proliferation Drives Aging-Related Functional Decline in a Subpopulation of the Hematopoietic Stem Cell Compartment
Kristina Kirschner et al.
CELL REPORTS (2017)
Myeloproliferative neoplasms: from origins to outcomes
Jyoti Nangalia et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Mesenchymal Stem Cells in Fibrotic Disease
Elie El Agha et al.
CELL STEM CELL (2017)
Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K. Schneider et al.
CELL STEM CELL (2017)
Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms
David A. Hinds et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
C. N. Harrison et al.
LEUKEMIA (2016)
Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells
Amit Grover et al.
NATURE COMMUNICATIONS (2016)
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
Jyoti Nangalia et al.
HAEMATOLOGICA (2015)
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov et al.
NATURE GENETICS (2015)
Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition
Qiang Jeremy Wen et al.
NATURE MEDICINE (2015)
Effect of Mutation Order on Myeloproliferative Neoplasms
Christina A. Ortmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms
William Tapper et al.
NATURE COMMUNICATIONS (2015)
JAK-STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
Maria Kleppe et al.
CANCER DISCOVERY (2015)
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
Jyoti Nangalia et al.
HAEMATOLOGICA (2015)
The JAK2 46/1 haplotype does not predispose to CALR-mutated myeloproliferative neoplasms
G. Soler et al.
ANNALS OF HEMATOLOGY (2015)
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
Raajit Rampal et al.
BLOOD (2014)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
WHO-histological criteria for myeloproliferative neoplasms: reproducibility, diagnostic accuracy and correlation with gene mutations and clinical outcomes
Alberto Alvarez-Larran et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union
Odile Moulard et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
Pontus Lundberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms
Lorena Arranz et al.
NATURE (2014)
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Raajit Rampal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations-The Danish experience
Ann Brinch Madelung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Myeloproliferative Neoplasia Remodels the Endosteal Bone Marrow Niche into a Self-Reinforcing Leukemic Niche
Koen Schepers et al.
CELL STEM CELL (2013)
Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease
Rafael Kramann et al.
JOURNAL OF PATHOLOGY (2013)
Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy
Alejandra Sanjuan-Pla et al.
NATURE (2013)
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
J. Nangalia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone
Anna L. Godfrey et al.
BLOOD (2012)
Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm
Yong Hou et al.
CELL (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Claire Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
Amy V. Jones et al.
BLOOD (2010)
A map of human genome variation from population-scale sequencing
David Altshuler et al.
NATURE (2010)
Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones
Philip A. Beer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V. Jones et al.
NATURE GENETICS (2009)
Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden
Ola Landgren et al.
BLOOD (2008)
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
Bridget S. Wilkins et al.
BLOOD (2008)
Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis
Stefan O. Ciurea et al.
BLOOD (2007)
Evidence for diversity in transcriptional profiles of single hematopoietic stem cells
Carlos A. Ramos et al.
PLOS GENETICS (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
CHM Jamieson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
分享论文
